Raymond James raises Nasdaq stock price target to $111 on earnings

NDAQ remains one of the cleaner “growth-with-quality” stories in market infrastructure, but the next leg is likely to come from multiple expansion rather than fundamental surprise. The key second-order effect is that a durable increase in retail options/equities participation lifts not just transaction revenue, but also pricing power across data, listings, and index licensing—businesses with higher retention and lower cyclicality than market services. That mix shift matters because it can compound EBITDA faster than headline volume growth and makes the stock less exposed to a single macro variable.

The bigger debate is whether the AI-disruption narrative is actually a discounting event or a real risk. If AI improves workflow efficiency for banks, brokers, and asset managers, Nasdaq can be a beneficiary through higher client productivity and more demand for market-data/analytics, not just a target. The real vulnerability is regulatory and competitive: if exchanges start competing harder on fees or if retail engagement normalizes faster than expected over the next 2-3 quarters, the market may have to de-rate the name from a “compounder” multiple toward a more market-sensitive infrastructure multiple.

The valuation setup looks constructive, but consensus may be underpricing the asymmetry around volatility. If options volumes stay elevated into rate-cut speculation or geopolitical shocks, earnings can accelerate because Nasdaq monetizes activity spikes with very little incremental cost. Conversely, if equity breadth broadens away from speculative trading, growth can decelerate without an obvious top-line collapse, which is the most dangerous scenario for the multiple.

The contrarian view is that the stock may be expensive on a normalized basis even if it looks reasonable versus near-term growth. The market is paying for persistence of elevated retail engagement and stable issuance conditions; both can fade quickly. That argues for respecting the name as a high-quality long, but not as a set-and-forget compounder unless the company can keep expanding recurring revenue faster than trading revenue cools.